CELL REP MED 润色咨询

CELL REPORTS MEDICINE

出版年份：暂无数据 年文章数：290 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-12-26 ITALIAN 来自上海

    审稿速度:24.0 | 投稿命中率:5.0
    偏重的研究方向：肿瘤
    经验分享：投稿1年，数次修回，暂无进展。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-11-20 ms7000000914996124 来自四川省

    无

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2022-04-23 susu2019

    审稿两个月了，希望能给个修回。

    27

    展开27条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-06-29 侠胆医心 来自香港

    2023年14.3分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-04-30 ms5000001932404434 来自上海

    无

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-04-30 ms5000001932404434 来自上海

    无

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-01-13 路LU 来自湖北省

    11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2023-01-10 ms6000002064617937 来自上海

    投稿命中率:25.0
    经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2022-03-27 chengan2015_64772396

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：准备投，先占位置，预计第一个影响因子15+

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2177325, encodeId=e95a21e732597, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向：肿瘤<br>经验分享：投稿1年，数次修回，暂无进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d361735891, createdName=ITALIAN, createdTime=Tue Dec 26 16:46:22 CST 2023, time=2023-12-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2169679, encodeId=968821696e98f, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon Nov 20 10:11:48 CST 2023, time=2023-11-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1213677, encodeId=475b12136e7ee, content=审稿两个月了，希望能给个修回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Apr 23 15:06:58 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145332, encodeId=8473214533219, content=2023年14.3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:51 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2129432, encodeId=85e32129432bc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:27:39 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2129433, encodeId=8832212943344, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682b8647575, createdName=ms5000001932404434, createdTime=Sun Apr 30 15:28:31 CST 2023, time=2023-04-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110099, encodeId=d78f21100996b, content=11.18号提交的，大概一两周under review，目前外审有一个多月了。有难度，但还是抱有一丝希望，有好消息就来更新状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=51225539981, createdName=路LU, createdTime=Fri Jan 13 20:22:32 CST 2023, time=2023-01-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109657, encodeId=5d53210965e9b, content=投稿命中率:25.0<br>经验分享：有没有人遇到过投稿几天后，变成“removed by editor”的情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=be1b8376397, createdName=ms6000002064617937, createdTime=Tue Jan 10 13:02:22 CST 2023, time=2023-01-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206499, encodeId=58f11206499e6, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：准备投，先占位置，预计第一个影响因子15+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9a95141895, createdName=chengan2015_64772396, createdTime=Sun Mar 27 23:28:40 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107796, encodeId=a0e3210e79651, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286c5403339, createdName=ms9000001631923037, createdTime=Wed Dec 28 11:12:41 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省)]
    2022-12-28 ms9000001631923037 来自浙江省

    1

    0

共86条页码: 2/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分